TY - JOUR
T1 - Prevalence of fetal alcohol spectrum disorders in 4 US communities
AU - May, Philip A.
AU - Chambers, Christina D.
AU - Kalberg, Wendy O.
AU - Zellner, Jennifer
AU - Feldman, Haruna
AU - Buckley, David
AU - Kopald, David
AU - Hasken, Julie M.
AU - Xu, Ronghui
AU - Honerkamp-Smith, Gordon
AU - Taras, Howard
AU - Manning, Melanie A.
AU - Robinson, Luther K.
AU - Adam, Margaret P.
AU - Abdul-Rahman, Omar
AU - Vaux, Keith
AU - Jewett, Tamison
AU - Elliott, Amy J.
AU - Kable, Julie A.
AU - Akshoomoff, Natacha
AU - Daniel, Falk
AU - Arroyo, Judith A.
AU - Hereld, Dale
AU - Riley, Edward P.
AU - Charness, Michael E.
AU - Coles, Claire D.
AU - Warren, Kenneth R.
AU - Jones, Kenneth Lyons
AU - Hoyme, H. Eugene
N1 - Publisher Copyright:
© 2018 American Medical Association. All rights reserved.
PY - 2018/2
Y1 - 2018/2
N2 - IMPORTANCE Fetal alcohol spectrum disorders are costly, life-long disabilities. Older data suggested the prevalence of the disorder in the United States was 10 per 1000 children; however, there are few current estimates based on larger, diverse US population samples. OBJECTIVE To estimate the prevalence of fetal alcohol spectrum disorders, including fetal alcohol syndrome, partial fetal alcohol syndrome, and alcohol-related neurodevelopmental disorder, in 4 regions of the United States. DESIGN, SETTING, AND PARTICIPANTS Active case ascertainment methods using a cross-sectional design were used to assess children for fetal alcohol spectrum disorders between 2010 and 2016. Children were systematically assessed in the 4 domains that contribute to the fetal alcohol spectrum disorder continuum: Dysmorphic features, physical growth, neurobehavioral development, and prenatal alcohol exposure. The settings were 4 communities in the Rocky Mountain, Midwestern, Southeastern, and Pacific Southwestern regions of the United States. First-grade children and their parents or guardians were enrolled. EXPOSURES Alcohol consumption during pregnancy. MAIN OUTCOMES AND MEASURES Prevalence of fetal alcohol spectrum disorders in the 4 communities was the main outcome. Conservative estimates for the prevalence of the disorder and 95%CIs were calculated using the eligible first-grade population as the denominator.Weighted prevalences and 95%CIs were also estimated, accounting for the sampling schemes and using data restricted to children who received a full evaluation. RESULTS A total of 6639 children were selected for participation from a population of 13 146 first-graders (boys, 51.9%; mean age, 6.7 years [SD, 0.41] and white maternal race, 79.3%). A total of 222 cases of fetal alcohol spectrum disorders were identified. The conservative prevalence estimates for fetal alcohol spectrum disorders ranged from 11.3 (95%CI, 7.8-15.8) to 50.0 (95%CI, 39.9-61.7) per 1000 children. The weighted prevalence estimates for fetal alcohol spectrum disorders ranged from 31.1 (95%CI, 16.1-54.0) to 98.5 (95%CI, 57.5-139.5) per 1000 children. CONCLUSIONS AND RELEVANCE Estimated prevalence of fetal alcohol spectrum disorders among first-graders in 4 US communities ranged from 1.1% to 5.0% using a conservative approach. These findings may represent more accurate US prevalence estimates than previous studies but may not be generalizable to all communities.
AB - IMPORTANCE Fetal alcohol spectrum disorders are costly, life-long disabilities. Older data suggested the prevalence of the disorder in the United States was 10 per 1000 children; however, there are few current estimates based on larger, diverse US population samples. OBJECTIVE To estimate the prevalence of fetal alcohol spectrum disorders, including fetal alcohol syndrome, partial fetal alcohol syndrome, and alcohol-related neurodevelopmental disorder, in 4 regions of the United States. DESIGN, SETTING, AND PARTICIPANTS Active case ascertainment methods using a cross-sectional design were used to assess children for fetal alcohol spectrum disorders between 2010 and 2016. Children were systematically assessed in the 4 domains that contribute to the fetal alcohol spectrum disorder continuum: Dysmorphic features, physical growth, neurobehavioral development, and prenatal alcohol exposure. The settings were 4 communities in the Rocky Mountain, Midwestern, Southeastern, and Pacific Southwestern regions of the United States. First-grade children and their parents or guardians were enrolled. EXPOSURES Alcohol consumption during pregnancy. MAIN OUTCOMES AND MEASURES Prevalence of fetal alcohol spectrum disorders in the 4 communities was the main outcome. Conservative estimates for the prevalence of the disorder and 95%CIs were calculated using the eligible first-grade population as the denominator.Weighted prevalences and 95%CIs were also estimated, accounting for the sampling schemes and using data restricted to children who received a full evaluation. RESULTS A total of 6639 children were selected for participation from a population of 13 146 first-graders (boys, 51.9%; mean age, 6.7 years [SD, 0.41] and white maternal race, 79.3%). A total of 222 cases of fetal alcohol spectrum disorders were identified. The conservative prevalence estimates for fetal alcohol spectrum disorders ranged from 11.3 (95%CI, 7.8-15.8) to 50.0 (95%CI, 39.9-61.7) per 1000 children. The weighted prevalence estimates for fetal alcohol spectrum disorders ranged from 31.1 (95%CI, 16.1-54.0) to 98.5 (95%CI, 57.5-139.5) per 1000 children. CONCLUSIONS AND RELEVANCE Estimated prevalence of fetal alcohol spectrum disorders among first-graders in 4 US communities ranged from 1.1% to 5.0% using a conservative approach. These findings may represent more accurate US prevalence estimates than previous studies but may not be generalizable to all communities.
UR - http://www.scopus.com/inward/record.url?scp=85041697147&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041697147&partnerID=8YFLogxK
U2 - 10.1001/jama.2017.21896
DO - 10.1001/jama.2017.21896
M3 - Article
C2 - 29411031
AN - SCOPUS:85041697147
SN - 0098-7484
VL - 319
SP - 474
EP - 482
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 5
ER -